Impaired Brain Energy Metabolism in the BACHD Mouse Model of Huntington's Disease: Critical Role of Astrocyte–Neuron Interactions
暂无分享,去创建一个
F. Petit | G. Bonvento | M. Beal | C. Jan | J. Mariani | E. Brouillet | P. Hantraye | C. Escartin | T. Delzescaux | N. Calingasan | N. Merienne | A. Hérard | L. Barros | M. Gaillard | R. Lerchundi | L. Boussicault | C. Malgorn | C. Véga | Nicolas Merienne | M. F. Beal | Luis F Barros | Fanny Petit | Nicolas Mérienne | L. F. Barros
[1] C. A. Toro,et al. A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice , 2013, Nature Communications.
[2] David Eidelberg,et al. Metabolic network as a progression biomarker of premanifest Huntington's disease. , 2013, The Journal of clinical investigation.
[3] Y. Chern,et al. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease. , 2013, Human molecular genetics.
[4] M. Frosch,et al. Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease. , 2013, Human molecular genetics.
[5] P. Detloff,et al. Purkinje cell dysfunction and loss in a knock-in mouse model of Huntington Disease , 2013, Experimental Neurology.
[6] R. Schreiber,et al. Motor, emotional and cognitive deficits in adult BACHD mice: A model for Huntington's disease , 2013, Behavioural Brain Research.
[7] A. Hannan,et al. Hippocampal Neurogenesis, Cognitive Deficits and Affective Disorder in Huntington's Disease , 2012, Neural plasticity.
[8] Jane S. Paulsen,et al. 8OHdG as a marker for Huntington disease progression , 2012, Neurobiology of Disease.
[9] S. Small,et al. R6/2 Huntington's Disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures , 2012, The Journal of Neuroscience.
[10] M. Hayden,et al. Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. , 2012, Human molecular genetics.
[11] Pierre J Magistretti,et al. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.
[12] R. Swanson,et al. Nuclear Factor Erythroid 2-Related Factor 2 Facilitates Neuronal Glutathione Synthesis by Upregulating Neuronal Excitatory Amino Acid Transporter 3 Expression , 2011, The Journal of Neuroscience.
[13] J. Mauer,et al. Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits. , 2011, Cell metabolism.
[14] Sarah A. Stern,et al. Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation , 2011, Cell.
[15] Fanny Mochel,et al. Energy deficit in Huntington disease: why it matters. , 2011, The Journal of clinical investigation.
[16] J. Lucas,et al. Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. , 2010, Free radical biology & medicine.
[17] M. MacDonald,et al. Cholesterol Defect Is Marked across Multiple Rodent Models of Huntington's Disease and Is Manifest in Astrocytes , 2010, The Journal of Neuroscience.
[18] Elena Cattaneo,et al. Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.
[19] S. Humbert,et al. pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking , 2010, Molecular Brain.
[20] Marc Dhenain,et al. Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease , 2010, NeuroImage.
[21] M. Guillermier,et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects , 2010, Human molecular genetics.
[22] Chuan-en Wang,et al. Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice* , 2010, The Journal of Biological Chemistry.
[23] N. Déglon,et al. Mitochondria in Huntington's disease. , 2010, Biochimica et biophysica acta.
[24] Chuan-en Wang,et al. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms , 2009, Proceedings of the National Academy of Sciences.
[25] Carlos Cepeda,et al. Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice , 2008, The Journal of Neuroscience.
[26] G. Egan,et al. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease , 2008, Brain Research Reviews.
[27] W. Frommer,et al. GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. , 2008, Biochimica et biophysica acta.
[28] Jane S. Paulsen,et al. Thalamic metabolism and symptom onset in preclinical Huntington's disease. , 2007, Brain : a journal of neurology.
[29] M. MacDonald,et al. Unbiased Gene Expression Analysis Implicates the huntingtin Polyglutamine Tract in Extra-mitochondrial Energy Metabolism , 2007, PLoS genetics.
[30] T. Videen,et al. Selective defect of in vivo glycolysis in early Huntington's disease striatum , 2007, Proceedings of the National Academy of Sciences.
[31] M. Beal,et al. Oxidative damage in Huntington's disease pathogenesis. , 2006, Antioxidants & redox signaling.
[32] Ji-Yeon Shin,et al. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity , 2005, The Journal of cell biology.
[33] M. Beal,et al. The Energetics of Huntington's Disease , 2004, Neurochemical Research.
[34] E. Welker,et al. Glial Glutamate Transporters Mediate a Functional Metabolic Crosstalk between Neurons and Astrocytes in the Mouse Developing Cortex , 2003, Neuron.
[35] R. Dantzer,et al. Long‐term modulation of glucose utilization by IL‐1α and TNF‐α in astrocytes: Na+ pump activity as a potential target via distinct signaling mechanisms , 2002 .
[36] R. Dantzer,et al. Long-term modulation of glucose utilization by IL-1 alpha and TNF-alpha in astrocytes: Na+ pump activity as a potential target via distinct signaling mechanisms. , 2002, Glia.
[37] Paolo Guidetti,et al. Early Degenerative Changes in Transgenic Mice Expressing Mutant Huntingtin Involve Dendritic Abnormalities but No Impairment of Mitochondrial Energy Production , 2001, Experimental Neurology.
[38] Marian DiFiglia,et al. Huntington Disease , 1998, Journal of neuropathology and experimental neurology.
[39] P Boesiger,et al. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease. , 1996, Brain : a journal of neurology.
[40] P. Magistretti,et al. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[41] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[42] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.